small molecule

NOXAFIL

POSACONAZOLE

Loss of exclusivityFebruary 2033latest FDA-listed patent expiry

CompanyMERCK SHARP AND DOHME CORP

Drug detail

Brand name	NOXAFIL
Active ingredient	POSACONAZOLE
Strength	300MG/16.7ML (18MG/ML)
Dosage form	SOLUTION
Route	INTRAVENOUS
Modality	Small molecule
FDA approval	March 2014
Marketing status	DISCN

Listed patents

Patent	Expires	Type
9493582	February 2033	product
9023790	July 2031	product
9358297	June 2031	product
9750822	March 2029	product
10117951	March 2029	product
8410077	March 2029	product

Regulatory exclusivity

Code	Expires
NPP	January 2029
ODE-355	June 2028

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Drug detail

Listed patents

Regulatory exclusivity

More from MERCK SHARP AND DOHME CORP